Use of proton pump inhibitors in adults in France: a nationwide drug utilization study.

Purpose: Proton pump inhibitor (PPI) drugs are approved for the management of gastric acid–related diseases, mainly treatment of gastroesophageal reflux disease, treatment of nonsteroidal anti-inflammatory drugs (NSAID)–related gastrointestinal complications and prevention in at-risk patients, Helic...

Full description

Bibliographic Details

Published in:	European Journal of Clinical Pharmacology Vol. 76; no. 3; pp. 449 - 458
Main Authors:	Lassalle, Marion, Le Tri, Thien, Bardou, Marc, Biour, Michel, Kirchgesner, Julien, Rouby, Frank, Dumarcet, Nathalie, Zureik, Mahmoud, Dray-Spira, Rosemary
Format:	research tables/charts Journal Article
Published:	Springer Nature Mar2020
Online Access:	View this record in EBSCOhost